Brief: Clinuvel Pharmaceuticals Says HY Profit After Tax A$11.4 Million
24/02/2023 01:29
Feb 24 (Reuters) - Clinuvel Pharmaceuticals CUV.AX :
* HY PROFIT AFTER TAX A$11.4 MILLION VERSUS A$5.9 MILLION
* HY REVENUES A$29.4 MILLION VERSUS A$24.6 MILLION
Source text for Eikon: ID:nASX5GXKD5
Further company coverage: CUV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist